Federal Register Notice for Hepatitis B Screening and Testing [ARCHIVED]
The content on this webpage is available for historical purposes. CDC is no longer reviewing or updating this content.
On April 4, 2022, the Centers for Disease Control and Prevention (CDC) published a Federal Register Notice (FRN) #CDC-2022-07050 to obtain comment on proposed hepatitis B screening and testing recommendations. The recommendations supplement CDC’s 2008 screening recommendations by including hepatitis B screening at least once in a lifetime for adults aged 18 years and older, using a three-test panel. Screening with three tests can help identify persons who have a current HBV infection, have resolved infection and who may be susceptible to reactivation, are susceptible and need vaccination, or are vaccinated.
The Federal Register Notice, docket number CDC-2022-0044, will be open for public comment for 60 days and closes on June 3, 2022.
Learn More about this Federal Register Notice
CDC hosted a webinar on April 20, 2022, at 2pm ET presenting an overview of the proposed recommendations.
Click here to view the webinar slides [PDF – 728 KB].
Questions?
Send questions about the FRN or how to post a comment to: DVHpolicy@cdc.gov